Related Experiment Video
Updated: May 13, 2026

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
Molecular diagnostics: parallels between infectious disease and emerging oncology testing
Joel A Lefferts1, Gregory J Tsongalis
1Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, Dartmouth Medical School, Department of Pathology, One Medical Center Drive, Lebanon, NH 03756, USA +1 603 650 5498 ; +1 603 650 4845 ; gregory.j.tsongalis@hitchcock.org.
Molecular oncology tests aid cancer diagnosis and treatment response prediction. Understanding these tests is crucial for clinicians and lab professionals, drawing parallels with established infectious disease molecular testing.
Area of Science:
- Clinical Laboratory Science
- Molecular Oncology
- Medical Diagnostics
Background:
- Molecular techniques are vital in modern medicine, especially in oncology.
- Advancements in understanding cancer and targeted therapies drive demand for new molecular tests.
- Clinicians and laboratorians face challenges in understanding emerging molecular oncology tests.
Purpose of the Study:
- To highlight the importance of molecular oncology tests in cancer care.
- To address the challenges in understanding and implementing these tests.
- To draw parallels with established molecular testing in infectious diseases to facilitate adoption in oncology.
Main Methods:
- Review of current molecular techniques in clinical laboratories.
- Comparison of molecular testing strategies in oncology and infectious diseases.
- Analysis of the impact of molecular tests on cancer diagnosis and treatment.
Main Results:
- Molecular oncology tests are essential for cancer diagnosis and predicting response to targeted therapies.
- A knowledge gap exists among healthcare professionals regarding these tests.
- Molecular testing in infectious diseases offers a model for understanding and implementing oncology assays.
Conclusions:
- Recognizing parallels with infectious disease molecular testing can accelerate the acceptance and utilization of molecular oncology assays.
- Improved understanding among clinicians and laboratorians is key to effective implementation.
- Molecular diagnostics are transforming cancer patient care through personalized medicine.
More Related Videos
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Modern Molecular Taxonomy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...